Prospective study on clinical characteristics of Japanese diabetic patients with chronic limb-threatening ischemia presenting Fontaine stage IV.
Critical limb-threatening ischemia
Diabetes-related complication
Fontaine stage IV
Prior history of ankle-brachial index measurement
Journal
Diabetology international
ISSN: 2190-1678
Titre abrégé: Diabetol Int
Pays: Japan
ID NLM: 101553224
Informations de publication
Date de publication:
Jan 2020
Jan 2020
Historique:
received:
07
04
2019
accepted:
10
06
2019
entrez:
18
1
2020
pubmed:
18
1
2020
medline:
18
1
2020
Statut:
epublish
Résumé
The aim of this prospective cross-sectional study was to reveal clinical characteristics of Japanese diabetic patients with chronic limb-threatening ischemia (CLTI) presenting ischemic unhealed ulcer/gangrene (Fontaine stage IV) in the real-world settings. The present study included 132 Japanese diabetic patients who underwent endovascular therapy for CLTI presenting Fontaine stage IV. The prevalence of diabetes-related complications, as well as prior history of ankle-brachial index (ABI) measurement before CLTI onset, was evaluated adopting multiple imputation (50 times). Duration of diabetes was referred to as time from diagnosis. The patients were aged 70 ± 10 years, with duration of diabetes 23 ± 12 years. The diabetes-related complications were so common that only 17% (95% confidence interval: 11-24%) and 25% (17-33%) of the population were free from advanced micro- and macroangiopathies, respectively. The clustering of advanced macroangiopathies was not significantly associated with duration of diabetes (
Identifiants
pubmed: 31950002
doi: 10.1007/s13340-019-00399-5
pii: 399
pmc: PMC6942079
doi:
Types de publication
Journal Article
Langues
eng
Pagination
33-40Informations de copyright
© The Japan Diabetes Society 2019.
Déclaration de conflit d'intérêts
Conflict of interestThe authors declare that they have no conflicts of interests associated with this manuscript.
Références
Diabetol Int. 2018 Mar 27;9(1):1-45
pubmed: 30603347
Eur J Vasc Endovasc Surg. 2007;33 Suppl 1:S1-75
pubmed: 17140820
BMJ Open Diabetes Res Care. 2016 Oct 3;4(1):e000294
pubmed: 27752329
Intern Med. 2013;52(22):2483-7
pubmed: 24240785
Hypertens Res. 2014 Apr;37(4):253-390
pubmed: 24705419
Circ J. 2013;77(2):456-61
pubmed: 23075764
Diabetes Care. 2010 May;33(5):977-82
pubmed: 20200304
BMJ Open Diabetes Res Care. 2016 Jan 25;4(1):e000123
pubmed: 26843962
Eur J Vasc Endovasc Surg. 2005 Jun;29(6):620-7
pubmed: 15878541
Ann Vasc Surg. 2014 May;28(4):983-9
pubmed: 24333196
Diabetologia. 2004 Mar;47(3):385-394
pubmed: 14985967
J Atheroscler Thromb. 2013;20(6):517-23
pubmed: 23665881
Diabetes Res Clin Pract. 1994 Oct;24 Suppl:S159-64
pubmed: 7859600
Eur J Neurol. 2013 Jun;20(6):921-7
pubmed: 23398285
Eur Heart J. 2018 Mar 1;39(9):763-816
pubmed: 28886620
Cardiovasc Diabetol. 2017 Apr 4;16(1):41
pubmed: 28376797
J Am Coll Cardiol. 2017 Mar 21;69(11):e71-e126
pubmed: 27851992
Diabetol Int. 2018 Dec 8;10(3):231-235
pubmed: 31275791
Adv Wound Care (New Rochelle). 2018 Jun 1;7(6):171-176
pubmed: 29892493
Eur J Vasc Endovasc Surg. 2017 Feb;53(2):206-213
pubmed: 27889202
Diabetes Care. 2008 Aug;31(8):1679-85
pubmed: 18663232
Diabetes. 1996 Jul;45 Suppl 3:S14-6
pubmed: 8674881
Horm Metab Res. 2002 Sep;34(9):509-15
pubmed: 12384828
J Diabetes Investig. 2017 Mar;8(2):243-249
pubmed: 27390272
Circ Cardiovasc Interv. 2017 Dec;10(12):null
pubmed: 29246911
J Diabetes Investig. 2015 Mar;6(2):242-6
pubmed: 25802733